References
- Center for Disease Control and Prevention, National Center for Injury Prevention and Control. Heroin overdose date. Washington (DC): Office of Associate Director for Communication, Digital Media Branch, Division of Public Affairs; 2019 March 30 [accessed 2019 June 20]. Available from https://www.cdc.gov/drugoverdose/data/heroin.html.
- Substance Abuse and Mental Health Services Administration. Medication and Counseling Treatment. U.S. Department of Health and Human Services. [accessed 2020 June 24]. Available from https://www.samhsa.gov/medication-assisted-treatment/treatment#medications-used-in-mat.
- Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. Rockville (MD): Center for Behavioral Health Statistics and Quality; 2018 September [accessed 2019 June 24]. Available from https://www.samhsa.gov/data/report/2017-nsduh-annual-national-report.
- National Institute on Drug Abuse. Medications to Treat Opioid Use Disorder. Rockville (MD): National Institute on Drug Abuse; 2018 June [accessed 2019 June 24] Available from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/overview.
- Alderks C. Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities. The CBHSQ Report. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; August 2017.
- Buprenorphine sublingual tablets [package insert]. Columbus, Ohio: Roxane Laboratories, Indivior Inc.; 2015.
- Dolophine® Hydrochloride (Methadone hydrochloride tablets, USP) [package insert]. Columbus, Ohio: Roxane Laboratories, Inc.; 2014.
- Hines S, Theodorou STAN, Williamson ANNA, Fong D, Curry K. Management of acute pain in methadone maintenance therapy in patients. Drug Alcohol Rev. 2008;27(5):519–523. doi:https://doi.org/10.1080/09595230802245519.
- Opioid oral morphine milligram equivalent (MME) conversion factors table for prescription drug coverage. Baltimore (MD): Centers for Medicare & Medicaid Services; 2017 August [accessed 2021 June 11] Available from https://www.cms.gov/Medicare/Prescription-Drug-coverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQ-Conversion-Factors-Aug-2017.pdf
- Paglia A, Goderecci R, Ciprietti N, Lagorio M, Necozione S, Calvisi V. Pain management after total knee arthroplasty. J Clin Orthop Trauma. 2020;11(1):113–117. doi:https://doi.org/10.1016/j.jcot.2018.12.005.